SCM
NVO

Silverarc Capital Management’s Novo Nordisk NVO Stock Holding History

Silverarc Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-60,000
Closed -$5.46M – 80
2023
Q3 		$5.46M Buy
+60,000
New +$5.29M 1.65% 24

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Silverarc Capital Management's NVO Position: Q4 2023 in Review

Silverarc Capital Management sold out of Novo Nordisk (NVO) in Q4 2023, closing a stake of 60,000 shares — an estimated $5.46M sold.

Silverarc Capital Management first reported a position in NVO in Q3 2023 and held it in 1 quarter. The position peaked at $5.46M in Q3 2023. 1,512 funds tracked by Wall St. Rank hold NVO as of Q4 2023.

  • Silverarc Capital Management reported no remaining Novo Nordisk position as of Q4 2023 after selling out during the quarter.
  • Silverarc Capital Management sold 60,000 Novo Nordisk shares in Q4 2023, an estimated $5.46M.
  • Silverarc Capital Management first reported a position in Novo Nordisk in Q3 2023 and held it in 1 quarter.
  • Silverarc Capital Management's Novo Nordisk position peaked at $5.46M in Q3 2023.
  • 1,512 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2023.

Based on Silverarc Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.